China healthcare: taking the private route
China healthcare: taking the private route
Our View - Issue V, December 2014
China’s healthcare industry is facing inevitable change as it seeks to attract more foreign investment and encourage privatization of some public health facilities and services. In this issue, we outline the various reforms underway and how private capital is being used as an antidote to the nation’s overburdened healthcare system, in addition to the various options for investors.
© 2026 KPMG Huazhen LLP, a People's Republic of China partnership, KPMG Advisory (China) Limited, a limited liability company in Chinese Mainland, KPMG, a Macau SAR partnership, and KPMG, a Hong Kong SAR partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
The KPMG name and logo are trademarks used under license by the
independent member firms of the KPMG global organisation.
For more detail about the structure of the KPMG global organisation please visit https://kpmg.com/governance.